In metastatic, castration-resistant PCa, ~17–20% are histologically classified as SCNC5, consisting of tumor cells that show NE differentiation and are completely unresponsive to hormonal therapy due to inactivation of AR signaling. This evidence concerns the gene AR and neoplasm.